|
|
The molecular imaging research of chemokine receptor 4(CXCR4) |
CAO Xue-liang1, FU Peng2, JIANG Ting-jun1, LUAN Sha1, ZHAO Chang-jiu1 |
1.The Fourth Hospital of Harbin Medical University, Harbin 150001, China;
2.The First Hospital of Harbin Medical University, Harbin 150001, China) |
|
|
Abstract Objective: To investigate the possibility of using small interference RNA(siRNA) targeting human chemokine receptor 4(CXCR4) radiolabeled with 99mTc for diagnosing human breast cancer. Methods: Small interference RNA targeted to CXCR4 mRNA and negative control siRNA were synthesized and radiolabeled by 99mTc with the bifunctional chelator HYNIC. The labeling efficiency, radiochemical purity and stability were investigated. Animal models of nude mice bearing human breast cancer MDA-MB-231 were established, divided them into three groups, 10 mice in each group. 99mTcO4-, 99mTc-HYNIC- siRNA(interference group), 99mTc-HYNIC-siRNA(negative control group) were separately injected through tail vein to the three groups. After 99mTcO4-, 99mTc-HYNIC-siRNA(interference group), 99mTc-HYNIC-siRNA(negative control group) were introduced into these animal models, tumor images were acquired with SPECT, the ratio of T/M was calculated. The data were analyzed by two-sample t test and analysis of variance. Results: The labeling efficiency of siRNA(interference group) and siRNA(negative control group) were (61.26±2.47)% and (60.85±2.76)% respectively. The radiochemical purities were both above 90%. Incubated in fresh human serum and PBS for 30 min and 120 min at 37℃, respectively, probes’ properties remained stable in 2 hours. At 1, 4 and 10 h after injection of different probes, the T/M ratios of 99mTc-HYNIC-siRNA(interference group) were 3.486±0.145, 4.574±0.222 and 6.608±0.366, and that of 99mTc-HYNIC-siRNA(negative control group) were 1.286±0.189, 1.348±0.204 and 1.354±0.238, with 99mTcO4- group 1.317±0.164, 1.322±0.159 and 1.401±0.145 respectively, and there were statistically significant differences in different groups at every time spots. The ratios of T/M in 99mTcO4- group and 99mTc-HYNIC-siRNA(negative control group) were significantly lower than those in 99mTc-HYNIC-siRNA(interference group) at 1, 4, 10 h respectively(tcontrol=29.20, 33.84 and 38.07, 99mTcO4-=31.29, 37.61 and 41.86, all P<0.01), and the T/M ratios at 1 h, 4 h, 10 h of 99mTc-HYNIC-siRNA(negative control group) and 99mTcO4- groups were not significantly different(t=0.392, 0.318 and 0.533, all P>0.05). Conclusions: The 99mTc-HYNIC-siRNA(interference group) could specificity accumulated in breast cancer tissue. The imaging with 99mTc-HYNIC-siRNA may be a promising method for diagnosis of breast cancer.
|
Received: 28 July 2016
|
|
|
|
|
[1]Fire A, Xu SQ, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998, 391(6669): 806-811.
[2]张超,庞全海. siRNA与miRNA在生物体基因调控中沉默机制的比较[J]. 中国生物化学与分子生物学报,2012,28(5):393-398.
[3]崔照琼,张彦,李艳琼. RNAi技术应用新进展[J]. 安徽医药,2012,(3):283-285.
[4]Vindrieux D, Escobar P, Lazennec G. Emerging roles of chemokines in prostate cancer[J]. Endocrine-related Cancer, 2009, 16(3): 663-673.
[5]Han TT, Fan L, Li J, et al. Role of chemokines and their receptors in chronic lymphocytic leukemia: Function in microenvironment and targeted therapy[J]. Cancer Biol Ther, 2013, 15(1): 0-1.
[6]Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment[J]. Blood, 2006, 107(5): 1761-1767.
[7]Caruz A, Samsom M, Alonso JM, et al. Genomic organization and promoter characterization of human CXCR4 gene[J]. FEBS Lett, 1998, 426(2): 271-278.
[8]Hamm HE. The many faces of G protein signaling[J]. J Biol Chem, 1998, 273: 669-672.
[9]Keeley EC, Mehrad B, Strieter RM. CXC chemokines in cancer angiogenesis and metastases[J]. Adv Cancer Res, 2010, 106: 91-111.
[10]Tietz O, Kamaly N, Smith G, et al. Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents[J]. Am J Nucl Med Molecular Imaging, 2013, 3(4): 372-383.
[11]吴琼,张月红,付鹏,等. 99Tcm标记MDM2反义寡核苷酸对人前列腺癌细胞目的基因表达的影响[J]. 中华核医学与分子影像杂志,2014,34(2):125-129.
[12]张月红,赵长久,吴琼,等. 小鼠双微体扩增基因反义探针用于荷人前列腺癌裸鼠的显像研究[J]. 中华核医学与分子影像杂志,2014,34(1):48-52.
[13]康磊,王荣福,闫平,等. 99mTc标记的小干扰RNA探针的制备及稳定性评价[J]. 核化学与放射化学,2010,32(6):348-353.
[14]Fu P, Tian L, Cao X, et al. Imaging CXCR4 Expression with 99mTc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts[J]. Molecular Imaging Biol, 2016, 18(3): 353-359.
[15]McManus MT, Petersen CP, Haines BB, et al. Gene silencing using micro-RNA designed hairpins[J]. Rna, 2002, 8(6): 842-850. |
|
|
|